By Justice Elevated Club NYC Four more states are advancing legislation that would allow medical marijuana use inside hospitals for seriously and terminally ill patients. Colorado, Hawaii, Virginia, and Washington are all moving versions of what many call “Ryan’s Law” — bills designed to close a major gap in access. Here’s the issue. In many states where medical cannabis is legal, patients can use it at home — but once they enter a hospital, access often stops. Federal classification, liability concerns, and unclear policy have kept hospitals cautious. The result? Patients who rely on cannabis for pain management, nausea, appetite stimulation, or comfort suddenly lose that option during critical care. These new bills aim to fix that. Most proposals focus specifically on seriously or terminally ill patients and create structured guidelines. Smoking and vaping are typically prohibited. Facilities are not required to store or dispense cannabis. Policies often include safeguards allowing hospitals to pause participation if federal enforcement becomes an issue. This isn’t about turning hospitals into dispensaries. It’s about continuity of care. If a patient is using physician-approved medical cannabis as part of their treatment plan, access shouldn’t disappear at the hospital door. Healthcare is about outcomes, dignity, and patient-centered decisions — not outdated gray areas. What we’re witnessing is a broader shift in how cannabis is viewed within the healthcare system. The conversation is moving beyond legalization headlines and into real-world implementation. How does cannabis integrate into structured medical environments? How do states protect institutions while honoring patient rights? How do we maintain safety while expanding access? Those are serious policy questions — and lawmakers are finally addressing them. For the legal market, this also reinforces something important: regulation matters. Lab testing matters. Clear sourcing matters. Structured guidelines matter. If cannabis is going to be treated like medicine, it must be handled with the same transparency and accountability. This moment isn’t about hype. It’s about systems evolving. At Elevated Club NYC, we’ve always said legalization was about safety, transparency, and informed access. Watching states refine policy to support patients in hospital settings shows that the conversation is maturing. The cannabis industry isn’t just retail. It’s healthcare policy. It’s patient rights. It’s responsible regulation. Education is elevation. — Justice Elevated Club NYC

Over $2 million worth of illegal cannabis was seized in coordinated raids across Brooklyn and Rhinebeck this week. According to state officials, investigators confiscated hundreds of pounds of flower, edibles, and concentrates from unlicensed operations — including a smoke shop operating next to a daycare in Prospect-Lefferts Gardens. Let that sink in. New York fought hard to legalize cannabis. The goal wasn’t chaos — it was regulation, safety, transparency, and opportunity. When unlicensed storefronts cut corners, mimic licensed packaging, and sell untested products, it doesn’t just break the law — it erodes trust in the entire system. The Office of Cannabis Management continues to increase enforcement, padlocking illegal shops and targeting illicit grow sites. This isn’t about optics. It’s about public health, consumer protection, and building a sustainable legal market that actually works. Here’s the reality: If you don’t know where your cannabis is grown, who produced it, whether it was lab tested, or how it was stored — you’re taking a risk. Testing exists for a reason. Compliance exists for a reason. Transparency exists for a reason. And this moment matters for licensed operators across New York. Every enforcement action sends a message that the state is serious about stabilizing the market. It creates space for legitimate businesses to compete fairly. It protects communities. It protects consumers. It protects the future of legal cannabis in New York. At Elevated Club NYC, we believe education is elevation. Legal cannabis isn’t just about access — it’s about accountability. It’s about knowing what you’re consuming. It’s about supporting operators who respect the system and the community. New York’s cannabis industry is still evolving. There will be growing pains. There will be headlines. But there is also progress. The question isn’t whether enforcement should happen. The question is how we move forward — smarter, safer, and more intentional. Stay elevated. — Justice

By Justice, Elevated Club NYC Cannabis isn’t a simple topic anymore — and the conversation around it is evolving fast. Over the past few weeks, a trio of news reports and opinion pieces have thrust critical questions about cannabis safety, regulation, and public awareness into the spotlight. Whether you’re a seasoned consumer, a curious newcomer, or someone in between, understanding these developments matters. Here’s what’s going on — and why it matters to all of us in the cannabis community. 1. New Concerns Over What’s Not Being Tested in Cannabis Researchers at the University of Colorado Boulder have raised fresh alarms about the limits of current cannabis testing. According to a recent report, certain toxins — including compounds that aren’t yet screened for in marijuana products — are not being checked with the same rigor that we see in other industries like food. Experts warn that our existing testing frameworks may miss contaminants that could pose public health risks if left unmonitored. This isn’t a condemnation of cannabis itself — it’s a call to tighten up safety measures and expand what labs are required to look for so that consumers can be confident in what they’re buying. 2. States Aren’t Funding Public Cannabis Risk Education — Even When Laws Require It Massachusetts provides a vivid example of regulatory oversights beyond just lab testing. State law mandates science-based public awareness campaigns about the health risks tied to marijuana and THC consumption, but the legislature hasn’t funded these efforts in more than five years — even as cannabis tax revenues have soared, bringing in nearly $290 million last fiscal year. Public health advocates point to troubling indicators: anecdotes from educators and families report young people struggling with anxiety, memory issues, and other impacts related to cannabis use — all without adequate, science-grounded education efforts supported at the state level. This gap between law and action raises an important question: if we’re going to normalize cannabis responsibly, we also need to fully support education about how it affects brains and bodies, especially in younger or inexperienced users. 3. The Ongoing Debate Over Cannabis and Mental Health Risks Meanwhile, opinion voices like former New York Times reporter Alex Berenson — author of Tell Your Children: The Truth About Marijuana, Mental Illness and Violence — are pointing to emerging research and media coverage suggesting stronger links between cannabis use (particularly high-potency THC products) and psychiatric concerns like psychosis and severe mental health episodes. Berenson argues that warnings about mental health risks are finally breaking through public discourse now that researchers, families, and news outlets are discussing cases previously marginalized. While opinion pieces are not scientific consensus, they reflect a real cultural shift: more people are asking whether long-term or heavy cannabis use might carry risks that weren’t widely acknowledged in the early days of legalization. This is why leading scientists and public health experts emphasize that cannabis — like alcohol and tobacco — exists on a spectrum of use and effect: responsible adult use is very different from frequent heavy use or early adolescent use, and both regulators and consumers need information that reflects that nuance. So What Does This Mean for the Cannabis Community? At Elevated Club NYC, we believe in informed, empowered, and joyful cannabis experiences. Here’s what this trio of stories highlights: ✔ Consumers deserve transparency. Testing needs to be robust, comprehensive, and evolving as science uncovers new questions — not just focused on potency. ✔ Public education isn’t optional. Warnings and awareness campaigns shouldn’t be afterthoughts — they should be part of how we build a responsible marketplace. ✔ Dialogue matters. Even when it’s uncomfortable or controversial, honest conversations about mental health, addiction, youth use, and potency help shape safer practices for all. Our Commitment to You We will always advocate for science-backed safety standards, transparent communication, and a cannabis culture built on respect for both enjoyment and well-being. That’s what Elevated Club NYC stands for — elevation through knowledge, community, and choice. Smoke smart. Stay informed. Stay elevated. — Justice, Elevated Club NYC

A constitutional showdown is brewing — and it could reshape the future of cannabis. In Variscite NY Four, Inc. v. New York , the Second Circuit suggested states can’t dodge constitutional scrutiny just because cannabis remains illegal under the Controlled Substances Act . If you build a commercial market, you may have to play by interstate rules. But the United States Court of Appeals for the Ninth Circuit  recently signaled the opposite — arguing there may be no protected interstate cannabis commerce at all. Two circuits. Two constitutional visions. One industry at stake. If the Supreme Court steps in, this could determine whether states can continue protecting local operators — or whether national consolidation accelerates. At Elevated Club NYC, we believe quality, compliance, and community should matter more than scale. But constitutional doctrine doesn’t move on vibes. It moves on precedent. Read the full breakdown. Stay informed. Stay elevated.

By Justice, Elevated Club NYC New York City is officially cashing in on cannabis — and the numbers are rising fast. Tax revenue from adult-use cannabis continues to climb as more licensed dispensaries open across the five boroughs. The legal market is expanding. Storefronts are multiplying. And Albany is watching the tax dollars stack up. On paper, it looks like progress. But if you talk to people inside the industry, the conversation gets more complicated. Yes, revenue is up. Yes, the legal infrastructure is growing. But many operators are asking a bigger question: Are we maximizing the opportunity — or overcomplicating it? New York’s cannabis tax structure includes both state and city layers, and while that generates public revenue, it also raises retail prices. When prices rise too quickly in a competitive market, consumers adjust. Some shop around. Some buy less. Some drift back to unlicensed sellers who operate outside the tax structure entirely. At the same time, wholesale prices are compressing. More licenses mean more competition. More competition means tighter margins. For independent operators, sustainability becomes a balancing act. The culture is here. The demand is here. The storefronts are here. But structure matters. New York has one of the most dynamic cannabis markets in the country — fueled by culture, tourism, and a deeply rooted underground history that long predates legalization. The question now isn’t whether cannabis works in NYC. It clearly does. The real question is how we build a system that rewards legal operators, protects consumers, generates fair tax revenue, and eliminates the illicit market without strangling the businesses doing it the right way. Growth is happening. That’s undeniable. But sustainable growth requires thoughtful policy, realistic taxation, and continued enforcement against unlicensed operations — not just headlines about rising revenue. New York doesn’t need to be “high on its own supply.” It needs to be strategic. The opportunity here is generational. The market can be strong, compliant, profitable, and culturally authentic — all at once. But only if the framework supports long-term stability instead of short-term optics.

By Justice, Elevated Club NYC The numbers are in — and depending on who you ask, cannabis is either plateauing or preparing for its next expansion phase. In 2025, U.S. regulated cannabis sales are hovering around $30–31 billion. That includes roughly $23.9 billion in adult-use and $7.6 billion in medical sales. On paper, that’s nearly flat compared to 2024’s $30.1 billion. After years of explosive double-digit growth, that feels like a slowdown. But context matters. Wholesale flower prices have dropped to around $1,020 per pound — about a 10% year-over-year decline. That’s not a collapse. That’s a market maturing. Oversupply in legacy states like California, Colorado, and Oregon is compressing margins. Taxes are stacking up. Operators are feeling pressure. At the same time, cannabis tax revenue continues breaking records. Since 2014, states have collected nearly $25 billion in adult-use tax revenue — with $4.4 billion collected in 2024 alone. For perspective, alcohol taxes totaled $8.9 billion in 2024. Cannabis is officially in the room. Forecasts split from here. MJBiz projects combined U.S. sales climbing toward $53.5 billion by 2027. Whitney Economics expects a slight dip in 2025. Statista predicts the U.S. market could reach $47 billion by 2026. Different models. Different assumptions. Same underlying reality: this is no longer a startup industry — it’s a regulated consumer category. And while mature states are stabilizing, limited-license markets are still ramping. New Jersey is tightening hemp rules. Virginia lawmakers are advancing legalization bills. Montana just crossed the $1 billion sales milestone. The federal government is even moving on CBD policy — with CMS finalizing Medicare CBD coverage. That’s not retrenchment. That’s normalization. The real shift isn’t revenue — it’s strategy. In the early days, being licensed was enough. Today, survival depends on branding, operational discipline, and consumer trust. The wholesale price compression separating strong operators from weak ones is the same pressure that builds real brands. At Elevated Club NYC, we see this phase as evolution. The market isn’t shrinking. It’s refining. Consumers are more educated. Product standards are higher. Expectations are sharper. Premium positioning matters more than ever. Cannabis isn’t chasing hype anymore. It’s becoming infrastructure. And when industries mature, the ones that endure are the ones that built intentionally from the start.

By Justice On February 17, 2026, Virginia lawmakers took a major step toward launching a fully regulated adult-use cannabis market. Both chambers of the state legislature passed bills that would finally allow licensed, taxed dispensaries to operate — transforming Virginia from a possession-legal state into a full commercial cannabis market. Virginia legalized adult possession and limited home cultivation in 2021, but retail sales never launched. These new bills aim to close that gap. If signed into law, adults 21+ will be able to purchase cannabis through regulated dispensaries, creating a structured marketplace designed to generate tax revenue and ensure product safety. The reforms go beyond retail sales. Lawmakers also approved measures that would allow automatic resentencing for certain non-violent cannabis offenses — a move that could reduce prison populations and address long-standing inequities tied to cannabis enforcement. In addition, hospitals would be permitted to facilitate medical cannabis use for qualifying patients, expanding patient access in clinical settings. Retail sales could begin as early as late 2026, pending the governor’s signature and regulatory rollout. For the East Coast, this is significant. With neighboring states already operating adult-use markets, Virginia’s entry would strengthen regional competition and accelerate the normalization of regulated cannabis commerce in the Mid-Atlantic. The broader implication? The East Coast cannabis market is maturing. States are moving from policy debates to implementation — building systems that balance revenue, regulation, and reform. As the industry evolves, one thing is clear: legalization is no longer just about access. It’s about structure, equity, and economic opportunity.

A recent flight from London to Los Angeles turned into an unexpected cannabis headline. After landing, several British Airways cabin crew members reportedly consumed gummies gifted by a passenger — unaware the candy allegedly contained high-dose THC. Shortly after, three crew members began feeling unwell, experiencing symptoms like anxiety and disorientation. They were taken to a Los Angeles hospital for evaluation and later released. The return flight required a replacement crew, and those affected were flown back to the UK as passengers. While cannabis is legal in California, it remains federally illegal in U.S. airspace — and airline policies strictly prohibit possession or use by crew members on duty. Reports indicate the crew did not know the gummies contained THC. This incident raises bigger questions: • Should airline staff accept edible gifts from passengers? • How aware are travelers of dosage strength (300mg is extremely high)? • What happens when state legalization meets federal aviation law? As cannabis continues to expand globally, moments like this highlight the importance of transparency, labeling, and responsible consumption.

A new study from Drug Rehab USA  surveyed 1,000 people with recent dating experience to understand how substance use in a potential partner is perceived. The results reveal something important: context matters more than stigma — and not all substances are viewed the same. According to the survey, “hard drug” use remains an immediate dealbreaker for the overwhelming majority of singles. Heavy alcohol use also raises red flags, particularly when it signals instability or lack of control. But cannabis? That’s where things get nuanced. Many respondents reported that moderate cannabis use is either acceptable or neutral — especially in states where it’s legal and culturally normalized. The perception shifts when usage appears excessive, secretive, or disruptive to ambition and lifestyle. In other words, it’s not simply what someone consumes. It’s how they show up while doing it. As someone building a premium cannabis brand in New York, this doesn’t surprise me. Cannabis today isn’t the stereotype many people grew up with. It’s wellness, creativity, decompression after long workdays, and — when consumed responsibly — a shared social experience. But like anything else, moderation defines perception. The dating world operates on signals. People assess stability, health, ambition, and emotional awareness. Substance use becomes shorthand for those traits. A glass of wine at dinner reads differently than daily blackouts. A pre-roll shared on a rooftop reads differently than unmotivated isolation. What this study really highlights is maturity in modern dating culture. Singles are less concerned with blanket judgments and more focused on alignment. Do your habits match mine? Does your lifestyle elevate or distract? Are you conscious and intentional? For cannabis consumers in New York, especially in a regulated adult-use market, the conversation has evolved. Transparency, legality, and responsible branding have reshaped perception. The stigma hasn’t vanished, but it’s shifting. At Elevated Club NYC, we believe cannabis should complement your life — not define it. It should enhance connection, spark conversation, and help you unwind, not derail ambition or relationships. The survey reminds us that self-awareness is attractive. Balance is attractive. Ownership of your habits is attractive. Dating in 2026 isn’t about pretending you’re perfect. It’s about being aligned. And when it comes to substance use, intention speaks louder than assumption. Education is elevation. — Justice Elevated Club NYC

In February 2026, headlines across sports and political media carried unexpected news: Donald Trump  issued presidential pardons to several former NFL players — including longtime Nate Newton . For many in the cannabis and criminal justice reform space, the moment sparked deeper conversations than football. Newton, a three-time Super Bowl champion with the Dallas Cowboys, had served time following a 2002 federal drug trafficking conviction. Decades later, standing in front of cameras with visible emotion, he described the pardon as “a blessing” and a “second chance.” His reaction wasn’t political — it was personal. It was about redemption, dignity, and being seen beyond your worst mistake. Reports indicate Newton was informed by Cowboys owner Jerry Jones , a moment that symbolized something bigger than clemency. It was acknowledgment. It was closure. And it was public recognition that people can evolve. The clemency announcement also included former players like Jamal Lewis , who had served time on drug-related charges earlier in his career. The reactions across sports media were mixed — some praised the move as an act of compassion, others questioned the broader criminal justice system that leads to these convictions in the first place. And that’s where the real conversation begins. For decades, drug enforcement policy has disproportionately impacted communities of color. Many individuals — athletes, artists, entrepreneurs — have carried the long shadow of convictions long after they’ve paid their debt. The pardons reignited a familiar debate: Who gets second chances? And why does it take fame or status to receive them? At Elevated Club NYC, we operate in a post-prohibition cannabis economy that still bears the scars of the war on drugs. While legal markets expand and billion-dollar valuations dominate headlines, thousands remain affected by past convictions tied to the same plant now sold legally across state lines. Newton’s emotional response wasn’t just about clearing a record. It was about relief. About being able to move forward without the weight of a federal conviction attached to his name. That human reaction is what stood out most. Redemption stories resonate because they reflect possibility. They remind us that reform isn’t abstract — it’s personal. And while presidential pardons are rare and selective, they shine a spotlight on a broader issue: justice should not depend on celebrity. Second chances shouldn’t be exceptional. They should be accessible.

Clarity Over Confusion By Justice, Elevated Club NYC Since the 2018 Farm Bill legalized hemp federally, a new category of cannabinoids has surged into the spotlight — Delta-8, Delta-10, HHC, and other hemp-derived compounds. They’re sold online, in smoke shops, even in places where traditional cannabis remains restricted. But what exactly are these products — and why are they surrounded by so much confusion? The Farm Bill defined hemp as cannabis containing less than 0.3% Delta-9 THC. What it didn’t clearly address was what happens when hemp-derived CBD is chemically converted into other psychoactive cannabinoids. Delta-8 THC does occur naturally in cannabis — but only in very small amounts. Most commercial Delta-8 products are created through laboratory conversion processes that transform CBD into Delta-8 using solvents and chemical reactions. That technical detail is where the regulatory gray zone begins. Federal law restricts “synthetically derived” tetrahydrocannabinols, but regulators have debated whether converted cannabinoids fall into that category. Meanwhile, the FDA has raised concerns about inconsistent testing, residual contaminants, and lack of standardized oversight. States have responded differently — some banning Delta-8 outright, others regulating it, and some leaving it largely unaddressed. The result? A patchwork of laws and interpretations across the country. The bigger issue isn’t hemp versus cannabis. It’s regulation versus loopholes. Consumers deserve transparency. Verified lab results. Clear labeling. Consistent safety standards. When products operate in legal gray areas, oversight often becomes inconsistent — and that affects quality and consumer confidence. At Elevated Club NYC, we believe education builds trust. Understanding how cannabinoids are produced, regulated, and tested empowers consumers to make informed decisions. In a growing market, clarity should never be optional. Clarity over confusion. — Justice Elevated Club NYC

By Justice, Elevated Club NYC A recent opinion piece in The Wall Street Journal  titled “This Isn’t Your Parents’ ‘Woodstock Weed’” argues that modern cannabis is dramatically more potent than the flower of the 1960s and 70s — and that legalization efforts, like Florida’s Amendment 3, risk unleashing dangerously high THC levels into the mainstream. Let’s unpack that. Yes — today’s cannabis is stronger. Decades ago, THC levels averaged around 2–5%. Today, premium indoor flower can range from 18–30%, with concentrates climbing much higher. That’s not mythology. That’s cultivation science, better genetics, and regulated lab testing. But potency alone doesn’t define risk. Context does. In regulated markets like New York, consumers aren’t buying mystery brick weed. They’re purchasing lab-tested products with clearly labeled THC percentages, terpene profiles, and dosage guidance. That transparency didn’t exist at Woodstock. Ironically, legalization is what creates accountability — not chaos. The debate shouldn’t be framed as “old weed good, new weed dangerous.” It should be framed around education, responsible consumption, age restrictions, and smart regulation. Alcohol today is stronger and more varied than it was 100 years ago. That didn’t end the conversation — it refined it. High-THC products aren’t for everyone. Just like high-proof liquor isn’t for everyone. The key is informed choice. Consumers deserve access to information, not fear-based headlines. At Elevated Club NYC, we believe education is elevation. We advocate: • 21+ responsible use • Clear potency labeling • Start-low, go-slow guidance • Respect for individual tolerance The plant has evolved. The market has evolved. The conversation should evolve too. This isn’t your parents’ Woodstock weed. It’s regulated. It’s tested. It’s transparent. And in places doing it right, it’s safer than ever. — Justice Elevated Club NYC